You just read:

OncoSec Medical's Intratumoral Plasmid IL-12 Demonstrates Effectiveness at Enhancing Tumor Immunogenicity in Preclinical Tumor Models

News provided by

OncoSec Medical Incorporated

21 Mar, 2017, 14:01 ET